Literature DB >> 33255843

Correlation between the Expression of Angiogenic Factors and Stem Cell Markers in Human Uveal Melanoma.

Klára Fodor1, Éva Sipos1, Nikoletta Dobos1, János Nagy2, Zita Steiber3, Gábor Méhes4, Kata Dull4, Lóránt Székvölgyi5, Andrew V Schally6,7, Gábor Halmos1,6.   

Abstract

Uveal melanoma (UM) is the most common malignant tumor of the eye with extremely high metastatic potential. UM tumor cells can disseminate only hematogenously, thus, angiogenic signals have a particular role in the prognosis of the disease. Although the presence of cancer stem cells (CSCs) in densely vascularized UMs has been reported previously, their role in the process of hematogenous spread of UM has not been studied. In this study, we investigated the regulation of angiogenesis in UM in correlation with the presence of CSCs. Seventy UM samples were collected to analyze the expression of CSC markers and angiogenic factors. The expression of CSC markers was studied by RT-PCR, Western blotting techniques and IHC-TMA technique. RT-PCR showed high expression of CSC markers, particularly nestin, FZD6 and SOX10 and somewhat lower expression of NGFR. The protein expression of FZD6, HIF-1α and VEGFA was further evaluated in 52 UM samples by the IHC-TMA technique. We report here for the first time a significant correlation between FZD6 and VEGFA expression in UM samples. The observed correlation between FZD6 and VEGFA suggests the presence of CSCs in UM that are associated with the vascularization process.

Entities:  

Keywords:  FZD6; VEGFA; angiogenesis; cancer stem cell; uveal melanoma

Year:  2020        PMID: 33255843      PMCID: PMC7760175          DOI: 10.3390/life10120310

Source DB:  PubMed          Journal:  Life (Basel)        ISSN: 2075-1729


  49 in total

Review 1.  Beyond tumorigenesis: cancer stem cells in metastasis.

Authors:  Feng Li; Benjamin Tiede; Joan Massagué; Yibin Kang
Journal:  Cell Res       Date:  2007-01       Impact factor: 25.617

2.  Neoadjuvant intravitreal ranibizumab treatment in high-risk ocular melanoma patients: a two-stage single-centre phase II single-arm study.

Authors:  Rumana N Hussain; Heinrich Heimann; Bertil Damato
Journal:  Melanoma Res       Date:  2020-02       Impact factor: 3.599

3.  The impact of intravitreal bevacizumab therapy on choroidal melanoma.

Authors:  Breno R Lima; Lynn R Schoenfield; Arun D Singh
Journal:  Am J Ophthalmol       Date:  2010-12-18       Impact factor: 5.258

4.  Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth.

Authors:  Gianluca Civenni; Anne Walter; Nikita Kobert; Daniela Mihic-Probst; Marie Zipser; Benedetta Belloni; Burkhardt Seifert; Holger Moch; Reinhard Dummer; Maries van den Broek; Lukas Sommer
Journal:  Cancer Res       Date:  2011-03-10       Impact factor: 12.701

5.  Uveal melanoma cell lines contain stem-like cells that self-renew, produce differentiated progeny, and survive chemotherapy.

Authors:  Helen Kalirai; Bertil E Damato; Sarah E Coupland
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-10-31       Impact factor: 4.799

6.  A genomewide study identifies the Wnt signaling pathway as a major target of p53 in murine embryonic stem cells.

Authors:  Kyoung-Hwa Lee; Mangmang Li; Aleksandra M Michalowski; Xinyue Zhang; Hongling Liao; Lingyi Chen; Yang Xu; Xiaolin Wu; Jing Huang
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-14       Impact factor: 11.205

7.  Stem cell marker CD271 is expressed by vasculogenic mimicry-forming uveal melanoma cells in three-dimensional cultures.

Authors:  Klara Valyi-Nagy; Bernadett Kormos; Mohamed Ali; Deepak Shukla; Tibor Valyi-Nagy
Journal:  Mol Vis       Date:  2012-03-02       Impact factor: 2.367

8.  Uptake of Ranibizumab but Not Bevacizumab into Uveal Melanoma Cells Correlates with a Sustained Decline in VEGF-A Levels and Metastatic Activities.

Authors:  Aysegül Tura; Vera E Pawlik; Martin Rudolf; Justus S Ernesti; Jan-Niklas Stutzer; Salvatore Grisanti; Mahdy Ranjbar
Journal:  Cancers (Basel)       Date:  2019-06-21       Impact factor: 6.639

9.  Tumour Angiogenesis in Uveal Melanoma Is Related to Genetic Evolution.

Authors:  Niels J Brouwer; Gülçin Gezgin; Annemijn P A Wierenga; Inge H G Bronkhorst; Marina Marinkovic; Gregorius P M Luyten; Mieke Versluis; Wilma G M Kroes; Pieter A van der Velden; Robert M Verdijk; Martine J Jager
Journal:  Cancers (Basel)       Date:  2019-07-13       Impact factor: 6.639

10.  Hypoxia-inducible factor 1 upregulation of both VEGF and ANGPTL4 is required to promote the angiogenic phenotype in uveal melanoma.

Authors:  Ke Hu; Savalan Babapoor-Farrokhran; Murilo Rodrigues; Monika Deshpande; Brooks Puchner; Fabiana Kashiwabuchi; Syed Junaid Hassan; Laura Asnaghi; James T Handa; Shannath Merbs; Charles G Eberhart; Gregg L Semenza; Silvia Montaner; Akrit Sodhi
Journal:  Oncotarget       Date:  2016-02-16
View more
  1 in total

1.  Spheroid-induced heterogeneity and plasticity of uveal melanoma cells.

Authors:  Yao Chen; Xiaoqin Lu; Ling Gao; Douglas C Dean; Yongqing Liu
Journal:  Cell Oncol (Dordr)       Date:  2022-04-11       Impact factor: 7.051

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.